AKT1 and acute myeloid leukemia: In spite of this evidence, the role of AMPK, mTORC1 and/or PI3K/AKT in AML cells is still controversial, having both tumor-suppressor and -promoter functions been assigned to these actors [48,52,56,60,61,62,63,64,65].